Existing malaria test found to be useful for predicting anemia risk from standard treatment

July 7, 2017 by Bob Yirka, Medical Xpress report
Even after artesunate therapy eliminates malaria parasites, previously-infected red blood cells retain a protein called HRP2 on their surfaces, which can be used to predict post-treatment anemia. Credit: P.A. Ndour et al., Science Translational Medicine (2017)

(Medical Xpress)—An international team of researchers has found that an existing kit for malaria testing can be used to identify patients at risk of developing anemia after receiving the standard treatment for the disease. In their paper published in the journal Science Translational Medicine, the group describes their study using the test to predict a serious form of anemia called post-artesunate delayed hemolysis (PADH) on malaria patients and how well it worked.

Malaria, as most are aware, is a condition in which a invades the and causes sickness. Worldwide, over three billion people live in regions where infections are prevalent. The modern treatment for the condition is to give a group of medications called artemisinins (drugs which contain an active compound found in the Artemisia plant), which work reasonably well. But after taking the drug, some patients (less than 5 percent) develop PADH several weeks later, which often leads to kidney failure. Unfortunately, until now, there has been no way to tell which people will develop PADH prior to treatment. In this new effort, the researchers report that they have found a test that offers some degree of accuracy in detecting the likelihood of malaria patients developing anemia after treatment.

The test is called the BinaxNOW malaria test kit, and is already used to test patients to see if they have malaria. Upon hearing anecdotal evidence of the test serving as a predictor of PADH, the researchers set up a study to find out if such claims were true. They administered the test to 95 Bangladeshi people along with 53 French visitors, all suffering from malaria, who also all received an artesunate. The researchers report that the test was 89 percent correct when looking for sensitivity and 73 percent for specificity.

Microscopic images of malaria parasites reproducing inside infected red blood cells. Credit: P.A. Ndour et al., Science Translational Medicine (2017)

As part of a separate study, the researchers also gave 49 patients quinine instead of artemisinins to treat their malaria. Quinine, though once used extensively, is no longer prescribed as a for malaria because it has been found to cause other serious health problems. In their study, the found that patients given quinine did not demonstrate high levels of a protein called HRP2, which is what the BinaxNOW test measures to predict the likelihood of a patient developing PADH.

Microscopic images of malaria parasites reproducing inside infected red blood cells. Credit: P.A. Ndour et al., Science Translational Medicine (2017)

Explore further: Malaria drug association with hemolytic anemia unclear

More information: Measuring the Plasmodium falciparum HRP2 protein in blood from artesunate-treated malaria patients predicts post-artesunate delayed hemolysis, Science Translational Medicine  05 Jul 2017: Vol. 9, Issue 397, eaaf9377 , DOI: 10.1126/scitranslmed.aaf9377

Abstract
Artesunate, the recommended drug for severe malaria, rapidly clears the malaria parasite from infected patients but frequently induces anemia—called post-artesunate delayed hemolysis (PADH)—for which a simple predictive test is urgently needed. The underlying event in PADH is the expulsion of artesunate-exposed parasites from their host erythrocytes by pitting. We show that the histidine-rich protein 2 (HRP2) of the malaria parasite Plasmodium falciparum persists in the circulation of artesunate-treated malaria patients in Bangladesh and in French travelers who became infected with malaria in Africa. HRP2 persisted in whole blood (not plasma) of artesunate-treated patients with malaria at higher levels compared to quinine-treated patients. Using an optimized membrane permeabilization method, HRP2 was observed by immunofluorescence, Western blotting, and electron microscopy to persist in once-infected red blood cells from artesunate-treated malaria patients. HRP2 was deposited at the membrane of once-infected red blood cells in a pattern similar to that for ring erythrocyte surface antigen (RESA), a parasite invasion marker. On the basis of these observations, we developed a semiquantitative titration method using a widely available HRP2-based rapid diagnostic dipstick test. Positivity on this test using a 1:500 dilution of whole blood from artesunate-treated patients with malaria collected shortly after parasite clearance predicted subsequent PADH with 89% sensitivity and 73% specificity. These results suggest that adapting an existing HRP2-based rapid diagnostic dipstick test may enable prediction of PADH several days before it occurs in artesunate-treated patients with malaria.

Related Stories

Malaria drug association with hemolytic anemia unclear

January 11, 2013
(HealthDay)—Artesunate, a drug used in the treatment of severe malaria, may or may not be associated with hemolytic anemia, so the U.S. Centers for Disease Control and Prevention recommends close monitoring of patients ...

Simplified artesunate regimen is non-inferior to WHO-recommended malaria treatment

January 12, 2016
In African children, a 3-dose intramuscular (i.m.) artesunate regimen is non-inferior to the WHO-recommended regimen for the treatment of severe malaria, according to a trial published this week in PLOS Medicine. The trial, ...

Measuring immune response could be key to differentiating malaria from other infections

April 25, 2017
Analysing a patient's immune response could be key to quickly and accurately diagnosing malaria, according to research presented on World Malaria Day at the 27th European Congress of Clinical Microbiology and Infectious Diseases ...

Study reveals substantial misdiagnosis of malaria in parts of Asia

July 24, 2012
Substantial overdiagnosis and mistreatment of malaria is evident in south and central Asia, warns a study published in the British Medical Journal today.

New malaria tool shows which kids at greatest risk

May 8, 2013
Researchers at Michigan State University have identified a test that can determine which children with malaria are likely to develop cerebral malaria, a much more life-threatening form of the disease.

Recommended for you

Team develops new way to grow blood vessels

August 17, 2018
Formation of new blood vessels, a process also known as angiogenesis, is one of the major clinical challenges in wound healing and tissue implants. To address this issue, researchers from Texas A&M University have developed ...

New imaging technique can spot tuberculosis infection in an hour

August 16, 2018
Guided by glowing bacteria, researchers have devised an imaging technique that can diagnose live tuberculosis in an hour and help monitor the efficacy of treatments. That's particularly critical because many TB strains have ...

Obesity, infertility and oxidative stress in mouse egg cells

August 16, 2018
Excessive body fat is associated with negative effects on female fertility and pregnancy. In mice, maternal obesity impairs proper development of egg precursor cells called oocytes. In a recent paper published in Molecular ...

Research shows it's possible to reverse damage caused by aging cells

August 15, 2018
What's the secret to aging well? University of Minnesota Medical School researchers have answered it- on a cellular level.

This matrix delivers healing stem cells to injured elderly muscles

August 15, 2018
A car accident leaves an aging patient with severe muscle injuries that won't heal. Treatment with muscle stem cells from a donor might restore damaged tissue, but doctors are unable to deliver them effectively. A new method ...

Male tobacco smokers have brain-wide reduction of CB1 receptors

August 15, 2018
Chronic, frequent tobacco smokers have a decreased number of cannabinoid CB1 receptors, the "pot receptor", when compared with non-smokers, reports a study in Biological Psychiatry.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.